Pictet Asset Management
GILD icon

Pictet Asset Management’s Gilead Sciences GILD Stock Holding History

Pictet Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$317M Sell
2,511,962
-62,860
-2% -$8.28M 0.3% 75
2026
Q1 		$357M Buy
2,574,822
+218,308
+9% +$30.6M 0.38% 57
2025
Q4 		$291M Sell
2,356,514
-326,886
-12% -$39.7M 0.28% 83
2025
Q3 		$299M Buy
2,683,400
+46,281
+2% +$5.26M 0.29% 86
2025
Q2 		$292M Sell
2,637,119
-540,550
-17% -$57.5M 0.3% 89
2025
Q1 		$356M Sell
3,177,669
-34,985
-1% -$3.61M 0.4% 60
2024
Q4 		$297M Sell
3,212,654
-1,048,709
-25% -$94.4M 0.32% 79
2024
Q3 		$357M Buy
4,261,363
+1,679,854
+65% +$128M 0.39% 61
2024
Q2 		$177M Sell
2,581,509
-1,639,017
-39% -$109M 0.2% 124
2024
Q1 		$309M Sell
4,220,526
-812,871
-16% -$62.5M 0.34% 76
2023
Q4 		$408M Sell
5,033,397
-278,672
-5% -$21.7M 0.45% 49
2023
Q3 		$398M Buy
+5,312,069
New +$409M 0.49% 45

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pictet Asset Management's GILD Position: Q2 2026 in Review

Pictet Asset Management reduced its Gilead Sciences (GILD) stake by 2.4% in Q2 2026, selling an estimated $8.28M and leaving 2,511,962 shares worth $317M. The position accounts for 0.3% of the portfolio, ranked #75.

Pictet Asset Management first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $408M in Q4 2023. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pictet Asset Management held 2,511,962 shares of Gilead Sciences worth $317M as of Q2 2026.
  • Pictet Asset Management sold 62,860 Gilead Sciences shares in Q2 2026, an estimated $8.28M.
  • Gilead Sciences made up 0.3% of Pictet Asset Management's portfolio in Q2 2026, its #75 holding.
  • Pictet Asset Management first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Gilead Sciences position peaked at $408M in Q4 2023.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.